The information in this preliminary pricing supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities and Exchange Commission. This preliminary pricing supplement and the accompanying product supplement, underlying supplement, prospectus supplement and prospectus are not an offer to sell... (continue reading...)
The information in this preliminary pricing supplement is not complete and may be changed. A registration statement relating to these securities has been filed with the Securities and Exchange Commission. This preliminary pricing supplement and the accompanying product supplement, underlying supplement, prospectus supplement and prospectus are not an offer to sell... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE TO
TENDER OFFER STATEMENT UNDER SECTION 14(D)(1) OR 13(E)(1)
OF THE SECURITIES EXCHANGE ACT OF 1934
USVC VENTURE CAPITAL ACCESS FUND
(Name of Subject Company (Issuer))
USVC VENTURE CAPITAL ACCESS FUND
(Name of Filing Person(s) (Issuer))
Common Shares of Beneficial Interest (Title of Class of Securities)
N/A
(CUSIP... (continue reading...)
Filed Pursuant to Rule 424(b)(2)
Registration Statement Nos. 333-297506
333-297506-01
PRICING SUPPLEMENT TO THE PROSPECTUS DATED JULY 16, 2026 AND THE PRODUCT PROSPECTUS SUPPLEMENT DATED JULY 16, 2026
US$388,000
Nomura America Finance, LLC
Senior Global Medium-Term Notes, Series A
Fully and Unconditionally Guaranteed by Nomura Holdings, Inc.
Autocallable Contingent Coupon Barrier Notes Linked to the Class C Common Stock of Dell... (continue reading...)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): September 30, 2026
Q32 Bio Inc.
(Exact name of Registrant as Specified in Its Charter)
Delaware 001-38433 47-3468154
(State or Other... (continue reading...)
More SEC Filings
View Older Stories-
Form 8-K/A Reliance Global Group, For: Sep 23
-
Form 6-K TORONTO DOMINION BANK For: Sep 30
-
Form 424B2 CAMPBELL'S Co
-
Form FWP Citigroup Global Markets Filed by: Citigroup Global Markets Holdings Inc.
-
Form FWP CITIGROUP INC Filed by: CITIGROUP INC
-
Form 497 BNY Mellon ETF Trust
-
Form DEFA14A PUTNAM SUSTAINABLE LEADE
-
Form 424B2 Nomura America Finance,
-
Form 425 ODNB Financial Corp Filed by: ODNB Financial Corp
-
Form 424B2 Nomura America Finance,
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 6-K AMTD IDEA GROUP For: Sep 30
-
Form 6-K AMTD Digital Inc. For: Sep 30
-
Form D Augnition Global Investo
-
Form 8-K Rent the Runway, Inc. For: Sep 30
-
Form 8-K CARLSMED, INC. For: Sep 24
-
Form 6-K CytoMed Therapeutics For: Jun 30
-
Form 6-K Lion Group Holding Ltd For: Sep 30
-
Form 497 Natixis Funds Trust IV
-
Form 424B5 Digimarc Corp
-
Form 6-K Generation Essentials For: Sep 30
-
Form 497 BNY MELLON INDEX FUNDS,
-
Form 8-K Trio Petroleum Corp For: Sep 25
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 424B2 CITIGROUP INC
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 8-K FIRST REAL ESTATE INVEST For: Sep 29
-
Form 424B3 Rent the Runway, Inc.
-
Form 424B2 JPMORGAN CHASE & CO
-
Form 1-U Pacaso Inc. For: Sep 30
-
Form 424B2 CITIGROUP INC
-
Form D Augnition Global Investo
-
Form 8-K Luvulis Corp For: Sep 24
-
Form 6-K SASOL LTD For: Sep 30
-
Form 424B2 Trinity Capital Inc.
-
Form 497 BNY Mellon Investment
-
Form 497 BNY MELLON INVESTMENT
-
Form N-23C3A Connetic Venture Capital For: Sep 30
-
Form 6-K SASOL LTD For: Sep 30
-
Form 8-K Indaptus Therapeutics, For: Sep 29
-
Form FWP Morgan Stanley Finance Filed by: Morgan Stanley Finance LLC
-
Form F-1 Primagrove Ltd
-
Form D/A Oberweis International
-
Form 424B2 JPMORGAN CHASE & CO
-
Form FWP MORGAN STANLEY Filed by: MORGAN STANLEY
-
Form 6-K SASOL LTD For: Sep 30
-
Form FWP Morgan Stanley Finance Filed by: Morgan Stanley Finance LLC
-
Form 10-D WFRBS Commercial Mortgag For: Sep 17
-
Form FWP MORGAN STANLEY Filed by: MORGAN STANLEY
